Cargando…
The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
The treatment paradigm of non-small cell lung cancer (NSCLC) has evolved into oncogene-directed precision medicine. Identifying actionable genomic alterations is the initial step towards precision medicine. An important scientific progress in molecular profiling of NSCLC over the past decade is the...
Autores principales: | Zhang, Yi-Chen, Zhou, Qing, Wu, Yi-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654124/ https://www.ncbi.nlm.nih.gov/pubmed/29061113 http://dx.doi.org/10.1186/s13045-017-0536-6 |
Ejemplares similares
-
Liquid Biopsy, ctDNA Diagnosis through NGS
por: Lin, Chen, et al.
Publicado: (2021) -
Liquid Biopsy in Non-Small Cell Lung Cancer
por: Molina-Vila, Miguel A., et al.
Publicado: (2016) -
Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients
por: Papadopoulou, Eirini, et al.
Publicado: (2019) -
Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution
por: Heeke, Simon, et al.
Publicado: (2020) -
Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform
por: Mayo de las Casas, Clara, et al.
Publicado: (2019)